MACKAY MARTIN
SEC CIK 1414815 · EDGAR
BoughtSold
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
| 17 | MACKAY MARTIN | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-11 16:48 | 2026-05-08 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $177.62 | +2,845 | 17.1K | +20% | +$505.3K |
| DM | 2025-05-23 | 2025-05-21 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $134.98 | +1,761 | 13.5K | +15% | +$237.7K |
| DM | 2024-05-15 | 2024-05-13 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $228.41 | +931 | 12.2K | +8% | +$212.6K |
| 2023-07-05 | 2023-07-03 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $0.00 | +95 | 11.6K | +0.8% | $0 | |
| 2023-06-02 | 2023-05-31 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $0.00 | +338 | 11.5K | +3% | $0 | |
| D | 2023-05-17 | 2023-05-15 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $0.00 | +664 | 11.2K | +6% | $0 |
| DM | 2022-05-13 | 2022-05-11 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $0.00 | +841 | 10.2K | +9% | $0 |
| DM | 2022-01-12 | 2022-01-10+ | RLYB | Rallybio Corp | MACKAY MARTIN | CEO, Dir | P - Purchase | $10.35 | +10.0K | 282.6K | +4% | +$103.5K |
| DI | 2022-01-12 | 2021-07-28 | RLYB | Rallybio Corp | MACKAY MARTIN | CEO, Dir | J - Other | — | +436.5K | 436.5K | New | — |
| D | 2022-01-12 | 2021-07-28 | RLYB | Rallybio Corp | MACKAY MARTIN | CEO, Dir | J - Other | — | +272.6K | 272.6K | New | — |
| 2022-01-04 | 2022-01-03 | CRL | Charles River Laboratories | MACKAY MARTIN | Dir | A - Grant | $0.00 | +63 | 9,662 | +0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations